University of Arizona
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Arizona sits in the top decile of US sponsors by registered trial count (#101 of 15,742 sponsors by registered trial count).
University of Arizona: 349 sponsored US clinical trials, 56 recruiting.
University of Arizona sponsors 349 registered US clinical trials on ClinicalTrials.gov, 56 of them currently recruiting, and 213 completed. 21 of these trials are in Phase 3-4 (later-stage) and 100 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 6 trials.
Top-decile sponsor footprint
University of Arizona ranks in the top decile of sponsors by registered trial count (#101 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
213 of 260 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
349 total, page 7 of 7
Influenza Vaccination in the Emergency Department
NCT00822627
Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis
NCT00796809
The Vegetable Dose Response Study: Effects of Consumption on Inflammation and Oxidative Stress
NCT01454674
Human Breast Tissue Bioavailability of Topically Applied Limonene
NCT01459172
Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome
NCT00822679
Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer
NCT00702299
Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment
NCT00614666
Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast Cancer
NCT00693719
Topical Myristyl Nicotinate Cream on the Skin of Healthy Volunteers
NCT00619060
Personalized Exercise for Adolescents With Diabetes
NCT00686283
Jump-In: Building Better Bones
NCT00729378
Duloxetine for Perimenopausal Depression
NCT00517985
Diagnosis of Exercise-induced Bronchospasm (EIB) and Asthma in National Collegiate Athletic Association (NCAA) Division I Athletes
NCT00752167
Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin
NCT00601640
Telephone Counseling: Men With Prostate Cancer & Partners
NCT00822510
Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary Disease
NCT00394940
A Pilot Study of Effect of Dexmedetomidine on Sleep and Inflammation in Critically Ill Patients
NCT00405847
Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL
NCT00732498
Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation
NCT00698685
CHOICES: Family Physicians Treat Overweight Children
NCT01674920
Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors
NCT01172028
Studying Tumor Tissue Samples From Patients With Soft Tissue Sarcoma
NCT00900341
Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer
NCT00130520
Role of Pain Modulation in GERD Patients Who Failed Standard Dose Proton Pump Inhibitors (PPI)
NCT00251732
Selenium for Prevention of Adenomatous Colorectal Polyps
NCT00078897
Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer
NCT00699907
Acupuncture as Complementary Therapy for Cerebral Palsy
NCT00221247
Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants
NCT00091325
Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries
NCT00098800
Immune Response in Peripheral Blood of Patients With Colon Cancer
NCT00900432
Use of Omega-3 Fatty Acids for Perinatal Depression
NCT00402389
Topical Perillyl Alcohol in Treating Patients With Sun Damaged Skin and Actinic Keratoses
NCT00608634
Atomoxetine Pilot Study in Preschool Children With ADHD
NCT00517647
The Effects of a 16-Week Individualized, Intensive Strength Training Program in Patients With Rheumatoid Arthritis
NCT00327275
Moderate Physical Activity in Helping Patients Recover Physically and Emotionally From Stage II Or Stage III Colorectal Cancer
NCT00373022
Community-Based Programs for Improving Physical Function in People With Early Knee Osteoarthritis
NCT00586300
Neurological Effects of Chemotherapy and Radiation Therapy in Patients With Colon Cancer
NCT00410618
Selenium in Treating Patients With Prostate Cancer
NCT00752739
Multidisciplinary Study of Right Ventricular Dysplasia
NCT00024505
Studying Blood Samples in Women With Breast Cancer or a History of Breast Cancer
NCT00898703
Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis
NCT00021294
Family Consultation for Health-Compromised Smokers
NCT00400751
Echinacea Purpurea and Osteopathy in Children With Recurrent Otitis Media
NCT00689468
Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome
NCT00003415
Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer
NCT00003307
Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer
NCT00003082
High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer
NCT00003068
Bone Estrogen Strength Training
NCT00000399
Bupropion Treatment for Youth Smoking Cessation
NCT00344695
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 43 |
| Phase 2 | 57 |
| Phase 3 | 8 |
| Phase 4 | 13 |
Therapeutic Areas
What is open in the University of Arizona pipeline
56 recruiting of 349 indexed (16% open); 213 completed (61%).
Phase mix: 21 late (III/IV) vs 100 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Arizona: open-pipeline peers nationwide
Peers matched on 349 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of Arizona sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 349 trials (± recruiting share)
- Montefiore Medical Center · 345 trials · 19% recruiting
- National Institute of Mental Health (NIMH) · 343 trials · 12% recruiting
- Children's Oncology Group · 342 trials · 10% recruiting
- Ohio State University Comprehensive Cancer Center · 341 trials · 23% recruiting
Sponsors near 16% open enrollment (± trial volume)
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
- George Mason University · 16% recruiting · 25 trials
- University of California, San Francisco · 16% recruiting · 1,713 trials
- National Human Genome Research Institute (NHGRI) · 16% recruiting · 185 trials
Related
What to do with this University of Arizona page
349 registered trials is a research-attention snapshot, not an endorsement of University of Arizona or any single study.
- 56 of University of Arizona's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of Arizona studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Arizona pipeline card: 349 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.